New and emerging treatments in smoking cessation

Cindy Mui, Scott Sherman

Research output: Contribution to journalReview article

Abstract

• Objective: To review recently approved and emerging medications for smoking cessation. • Methods: Studies on newer smoking cessation aids were identified using MEDLINE (1996-2007), the Society for Research on Nicotine and Tobacco abstracts database, and the U.S. Patents and Trademark Office database. All randomized controlled trials evaluating 1 or more medications used in smoking cessation (including vaccines) were included. Phase 1 and animal studies were excluded. • Results: Varenicline has been effective in smoking cessation despite the unquantified risk of serious psychiatric effects. Rimonabant appears to be effective for smoking cessation and possibly relapse prevention and is generally well tolerated. Nicotine vaccines, mecamylamine, topiramate, and selegiline all appear effective for use in smoking cessation in preliminary trials, but additional studies are needed to confirm these findings both in the short and long term. • Conclusion: Currently available first-line treatments for smoking cessation include nicotine replacement (eg, nicotine patch, nicotine gum), bupropion, and varenicline and have proven efficacy in published studies. Several treatments currently under study appear promising.

Original languageEnglish (US)
Pages (from-to)545-552
Number of pages8
JournalJournal of Clinical Outcomes Management
Volume15
Issue number11
StatePublished - Nov 1 2008

Fingerprint

Smoking Cessation
Nicotine
rimonabant
Patents
Therapeutics
Vaccines
Databases
Tobacco Use Cessation Products
Mecamylamine
Selegiline
Bupropion
Secondary Prevention
MEDLINE
Psychiatry
Randomized Controlled Trials

ASJC Scopus subject areas

  • Medicine(all)
  • Health Policy

Cite this

New and emerging treatments in smoking cessation. / Mui, Cindy; Sherman, Scott.

In: Journal of Clinical Outcomes Management, Vol. 15, No. 11, 01.11.2008, p. 545-552.

Research output: Contribution to journalReview article

@article{51b7c986ec9d43fe93a6131761efbcf3,
title = "New and emerging treatments in smoking cessation",
abstract = "• Objective: To review recently approved and emerging medications for smoking cessation. • Methods: Studies on newer smoking cessation aids were identified using MEDLINE (1996-2007), the Society for Research on Nicotine and Tobacco abstracts database, and the U.S. Patents and Trademark Office database. All randomized controlled trials evaluating 1 or more medications used in smoking cessation (including vaccines) were included. Phase 1 and animal studies were excluded. • Results: Varenicline has been effective in smoking cessation despite the unquantified risk of serious psychiatric effects. Rimonabant appears to be effective for smoking cessation and possibly relapse prevention and is generally well tolerated. Nicotine vaccines, mecamylamine, topiramate, and selegiline all appear effective for use in smoking cessation in preliminary trials, but additional studies are needed to confirm these findings both in the short and long term. • Conclusion: Currently available first-line treatments for smoking cessation include nicotine replacement (eg, nicotine patch, nicotine gum), bupropion, and varenicline and have proven efficacy in published studies. Several treatments currently under study appear promising.",
author = "Cindy Mui and Scott Sherman",
year = "2008",
month = "11",
day = "1",
language = "English (US)",
volume = "15",
pages = "545--552",
journal = "Journal of Clinical Outcomes Management",
issn = "1079-6533",
publisher = "Turner White Communications Inc.",
number = "11",

}

TY - JOUR

T1 - New and emerging treatments in smoking cessation

AU - Mui, Cindy

AU - Sherman, Scott

PY - 2008/11/1

Y1 - 2008/11/1

N2 - • Objective: To review recently approved and emerging medications for smoking cessation. • Methods: Studies on newer smoking cessation aids were identified using MEDLINE (1996-2007), the Society for Research on Nicotine and Tobacco abstracts database, and the U.S. Patents and Trademark Office database. All randomized controlled trials evaluating 1 or more medications used in smoking cessation (including vaccines) were included. Phase 1 and animal studies were excluded. • Results: Varenicline has been effective in smoking cessation despite the unquantified risk of serious psychiatric effects. Rimonabant appears to be effective for smoking cessation and possibly relapse prevention and is generally well tolerated. Nicotine vaccines, mecamylamine, topiramate, and selegiline all appear effective for use in smoking cessation in preliminary trials, but additional studies are needed to confirm these findings both in the short and long term. • Conclusion: Currently available first-line treatments for smoking cessation include nicotine replacement (eg, nicotine patch, nicotine gum), bupropion, and varenicline and have proven efficacy in published studies. Several treatments currently under study appear promising.

AB - • Objective: To review recently approved and emerging medications for smoking cessation. • Methods: Studies on newer smoking cessation aids were identified using MEDLINE (1996-2007), the Society for Research on Nicotine and Tobacco abstracts database, and the U.S. Patents and Trademark Office database. All randomized controlled trials evaluating 1 or more medications used in smoking cessation (including vaccines) were included. Phase 1 and animal studies were excluded. • Results: Varenicline has been effective in smoking cessation despite the unquantified risk of serious psychiatric effects. Rimonabant appears to be effective for smoking cessation and possibly relapse prevention and is generally well tolerated. Nicotine vaccines, mecamylamine, topiramate, and selegiline all appear effective for use in smoking cessation in preliminary trials, but additional studies are needed to confirm these findings both in the short and long term. • Conclusion: Currently available first-line treatments for smoking cessation include nicotine replacement (eg, nicotine patch, nicotine gum), bupropion, and varenicline and have proven efficacy in published studies. Several treatments currently under study appear promising.

UR - http://www.scopus.com/inward/record.url?scp=57149109390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57149109390&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:57149109390

VL - 15

SP - 545

EP - 552

JO - Journal of Clinical Outcomes Management

JF - Journal of Clinical Outcomes Management

SN - 1079-6533

IS - 11

ER -